相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer
Lori J. Wirth et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer American Thyroid Association Anaplastic Thyroid Cancer Guidelines Task Force
Keith C. Bible et al.
THYROID (2021)
Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in lenvatinib treatment for anaplastic thyroid carcinoma
Haruhiko Yamazaki et al.
GLAND SURGERY (2021)
Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer
Mijin Kim et al.
ENDOCRINE (2021)
Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer
Dan Fan et al.
CANCER (2020)
Histological features of BRAF V600E-mutant anaplastic thyroid carcinoma
Tiffany Y. Chen et al.
HISTOPATHOLOGY (2020)
Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019
Anastasios Maniakas et al.
JAMA ONCOLOGY (2020)
Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis
Soo Young Kim et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Expression of Class III Beta-Tubulin Is Associated with Invasive Potential and Poor Prognosis in Thyroid Carcinoma
Hee Young Na et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib
Naoki Fukuda et al.
IN VIVO (2020)
The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer
Yasuhiro Ito et al.
ENDOCRINE JOURNAL (2020)
Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in anaplastic thyroid carcinoma
Haruhiko Yamazaki et al.
ENDOCRINE (2020)
Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer
Koichi Takayama et al.
ONCOLOGIST (2019)
Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma
Jennifer R. Wang et al.
THYROID (2019)
Case report: lenvatinib in neoadjuvant setting in a patient affected by invasive poorly differentiated thyroid carcinoma
Stefano Gay et al.
FUTURE ONCOLOGY (2019)
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
G. von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Tyrosine Kinase Inhibitor Therapy in Locally Advanced Differentiated Thyroid Cancer: A Case Report
Kirsten E. Stewart et al.
EUROPEAN THYROID JOURNAL (2019)
Efficacy of weekly administration of paclitaxel and carboplatin for advanced ovarian cancer patients with poor performance status
Hisamitsu Takaya et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2018)
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer
Vivek Subbiah et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
N. Masuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?
R. Michael Tuttle et al.
THYROID (2017)
Surgical treatment of locally advanced papillary thyroid carcinoma after response to lenvatinib: A case report
Mitsuhiro Tsuboi et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2017)
Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II study
L. M. Smyth et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
The Safety and Efficacy of Weekly Paclitaxel Administration for Anaplastic Thyroid Cancer Patients: A Nationwide Prospective Study
Naoyoshi Onoda et al.
THYROID (2016)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Efficacy of weekly paclitaxel in patients with advanced gastric cancer refractory to docetaxel-based chemotherapy
Takayuki Ando et al.
GASTRIC CANCER (2012)
High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non-Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
Guenaelle Levallet et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Prognostic Factors and Treatment Outcomes for Anaplastic Thyroid Carcinoma: ATC Research Consortium of Japan Cohort Study of 677 Patients
Iwao Sugitani et al.
WORLD JOURNAL OF SURGERY (2012)
Induction Chemotherapy with Weekly Paclitaxel Administration for Anaplastic Thyroid Carcinoma
Takuya Higashiyama et al.
THYROID (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid
I Sugitani et al.
WORLD JOURNAL OF SURGERY (2001)
Treatment of anaplastic thyroid carcinoma with paclitaxel: Phase 2 trial using ninety-six-hour infusion
KB Ain et al.
THYROID (2000)
分享论文
